XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 175 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,389 | -21.3% | 128,487 | -11.3% | 0.21% | -15.2% |
| Q2 2023 | $5,578 | +305.7% | 144,877 | +277.2% | 0.24% | +273.8% |
| Q1 2023 | $1,375 | -4.2% | 38,407 | +5.5% | 0.06% | -18.8% |
| Q4 2022 | $1,436 | -99.9% | 36,416 | -19.5% | 0.08% | -19.2% |
| Q3 2022 | $1,633,000 | +103.4% | 45,246 | +71.4% | 0.10% | +65.0% |
| Q2 2022 | $803,000 | +117.6% | 26,404 | +118.7% | 0.06% | +150.0% |
| Q1 2022 | $369,000 | – | 12,074 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |